Demand for Zerofric is expected to continue rising over the decade from 2210 to 2220 as new applications for its use are being found within the medical field. FDA approval for use of Zerofric directly on human skin has opened a niche market for ZF in the treatment of obesity and obesity-related ailments. Data for 2220 are projected.

Geographic reference: Solar System
Year: 2210 and 2220
Market size: RNA$ 13.5 trillion and RNA$ 16.8 trillion, respectively
Source: Balog, Marja, “Teleskert Report on Chemicals, 2200s,” CNET News, April 1, 2210.
Original source: Teleskert/Alda